Time to TreatmentWith Endovascular Thrombectomy andOutcomes From Ischemic Stroke : AMeta-analysis
暂无分享,去创建一个
A. Demchuk | Á. Chamorro | G. Donnan | C. Molina | A. Lugt | J. Saver | R. Oostenbrugge | T. Devlin | R. Nogueira | S. Davis | F. Silver | A. Siddiqui | M. Hill | C. Majoie | A. Dávalos | Scott C. Brown | H. Lingsma | B. Menon | M. Goyal | T. Jovin | O. Berkhemer | P. Fransen | Y. Roos | D. Dippel | P. Mitchell | W. V. Zwam | B. Campbell | P. Cardona | A. Tomasello | C. Castaño | B. Sapkota | D. Frei | A. Shuaib | B. Stouch | R. D. D. Rochemont | S. Davis | R. D. M. Rochemont | A. Siddiqui
[1] L. Derex,et al. Mechanical thrombectomy in acute ischemic stroke. , 2017, Revue neurologique.
[2] A. Demchuk,et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.
[3] H. Diener,et al. Analysis of Workflow and Time to Treatment and the Effects on Outcome in Endovascular Treatment of Acute Ischemic Stroke: Results from the SWIFT PRIME Randomized Controlled Trial. , 2016, Radiology.
[4] A. Demchuk,et al. Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial , 2016, Circulation.
[5] C. Molina,et al. Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion , 2016, Stroke.
[6] Ewout W Steyerberg,et al. Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial. , 2016, JAMA neurology.
[7] R. Raman,et al. Accuracy of First Recorded "Last Known Normal" Times of Stroke Code Patients. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[8] Elad I Levy,et al. Time to endovascular reperfusion and degree of disability in acute stroke , 2015, Annals of neurology.
[9] M. Chen,et al. Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery , 2015, Journal of NeuroInterventional Surgery.
[10] C. Sorensen,et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke , 2015 .
[11] H. Diener,et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. , 2015, The New England journal of medicine.
[12] A. Demchuk,et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. , 2015, The New England journal of medicine.
[13] M. Krause,et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.
[14] Hester F. Lingsma,et al. A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.
[15] Manabu Inoue,et al. The Growth Rate of Early DWI Lesions is Highly Variable and Associated with Penumbral Salvage and Clinical Outcomes following Endovascular Reperfusion , 2013, International journal of stroke : official journal of the International Stroke Society.
[16] Christopher S. Coffey,et al. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment , 2015 .
[17] P. Sandercock,et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .
[18] Michael D Hill,et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial , 2014, The Lancet Neurology.
[19] Marc Quinlan,et al. Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke , 2013 .
[20] Joanna M. Wardlaw,et al. Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A Consensus Statement , 2013, Stroke.
[21] J. Broderick,et al. Impact of Onset-to-Reperfusion Time on Stroke Mortality: A Collaborative Pooled Analysis , 2013, Circulation.
[22] P. Meyers,et al. Multisociety Consensus Quality Improvement Guidelines for Intraarterial Catheter-directed Treatment of Acute Ischemic Stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Card , 2013, AJNR. American journal of neuroradiology.
[23] V. Howard,et al. A Simple, Assumption-Free, and Clinically Interpretable Approach for Analysis of Modified Rankin Outcomes , 2012, Stroke.
[24] J. Grotta,et al. Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial , 2009, Stroke.
[25] J. Saver. Time Is Brain—Quantified , 2006, Stroke.
[26] W. Hacke,et al. Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic? , 2001, Stroke.
[27] Joseph P. Broderick,et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year , 1999 .